EE160 Tepotinib for the Treatment of Adult Patients with Metastatic Non-Small Cell Lung Cancer Harboring METEX14 Skipping Alterations: A US Cost-Effectiveness Analysis. - Yang, M; Sachdev, R; Stargardter, M; Tosh, J; Vioix, H (Value in Health, 2022)